SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Immunosyn Corp – ‘10-Q’ for 6/30/08 – EX-32.2

On:  Wednesday, 8/13/08, at 5:09pm ET   ·   For:  6/30/08   ·   Accession #:  950120-8-381   ·   File #:  0-52871

Previous ‘10-Q’:  ‘10-Q’ on 5/16/08 for 3/31/08   ·   Next:  ‘10-Q’ on 11/14/08 for 9/30/08   ·   Latest:  ‘10-Q’ on 11/19/10 for 9/30/10

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 8/13/08  Immunosyn Corp                    10-Q        6/30/08    5:285K                                   Thelen LLP/FA

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report for Period Ended June 30, 2008     HTML    150K 
 2: EX-31.1     Certification of Stephen D. Ferrone, Chief          HTML     16K 
                          Executive Officer, Pursuant to Section                 
                          302 of the Sarbanes-Oxley Act of 2002                  
 3: EX-31.2     Certification of Douglas A. McClain Jr., Chief      HTML     16K 
                          Financial and Accounting Officer,                      
                          Pursuant to Section 302 of the                         
                          Sarbanes-Oxley Act of 2002                             
 4: EX-32.1     Certification of Stephen D. Ferrone, Chief          HTML      9K 
                          Executive Officer, Pursant to Section                  
                          906 of the Sarbanes-Oxley Act of 2002                  
 5: EX-32.2     Certification of Douglas A. McClain Jr., Chief      HTML      9K 
                          Financial and Accounting Officer,                      
                          Pursuant to Section 906 of the Sarbanes                
                          -Oxley Act of 2002                                     


EX-32.2   —   Certification of Douglas A. McClain Jr., Chief Financial and Accounting Officer, Pursuant to Section 906 of the Sarbanes -Oxley Act of 2002


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 
Exhibit 32.2
 
IMMUNOSYN CORPORATION
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with this quarterly report of Immunosyn Corporation (the “Company”) on Form 10-Q for the quarter ended June 30, 2008 (the “Report”), I, Douglas A. McClain Jr., Chief Financial and Accounting Officer of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:
 
(1)           The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable,of the Securities Exchange Act of 1934, and
 
(2)           The information contained in the Report fairly presents, in all material respects, the consolidated financial condition and results of operations of the Company at the dates and for the periods indicated.
 
This Certification has not been, and shall not be deemed, “filed” with the Securities and Exchange Commission.
 
 
Date:  August 13, 2008
/s/ Douglas A. McClain Jr.
 
Douglas A. McClain Jr.
 
Chief Financial and Accounting Officer
 

Dates Referenced Herein

This ‘10-Q’ Filing    Date    Other Filings
Filed on:8/13/08None on these Dates
For Period End:6/30/08
 List all Filings 
Top
Filing Submission 0000950120-08-000381   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 5:48:33.1am ET